BRIM Biotechnology, Inc. (TPEX: 6885)
Taiwan
· Delayed Price · Currency is TWD
42.65
+0.35 (0.83%)
Nov 20, 2024, 2:58 PM CST
BRIM Biotechnology Revenue
BRIM Biotechnology had revenue of 66.00K TWD in the quarter ending September 30, 2024, with 46.67% growth. This brings the company's revenue in the last twelve months to 111.00K, down -63.96% year-over-year. In the year 2023, BRIM Biotechnology had annual revenue of 90.00K, down -82.89%.
Revenue (ttm)
111.00K
Revenue Growth
-63.96%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 90.00K | -436.00K | -82.89% |
Dec 31, 2022 | 526.00K | 166.00K | 46.11% |
Dec 31, 2021 | 360.00K | -90.41M | -99.60% |
Dec 31, 2020 | 90.77M | - | - |
Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition